SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.58 |
| Enterprise Value ($M) | 4.37 |
| Book Value ($M) | -5.19 |
| Book Value / Share | -0.49 |
| Price / Book | -0.69 |
| NCAV ($M) | -5.21 |
| NCAV / Share | -0.50 |
| Price / NCAV | -0.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -5.44 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.03 |
| Current Ratio | 0.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.16 |
| Assets | 0.18 |
| Liabilities | 5.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.24 |
| Operating Income | -0.42 |
| Net Income | -0.87 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -0.69 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.57 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| RBSH – Rebus Holdings, Inc. | RELV – Reliv' International, Inc. |
| REPCF – RepliCel Life Sciences Inc. | RGDXQ – Response Genetics, Inc |
| RGRX – RegeneRx Biopharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io